Page last updated: 2024-08-23

halofenate and Weight Gain

halofenate has been researched along with Weight Gain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clarke, HJ; Clemens, LE; Favelyukis, S; Gregoire, FM; Gustafson, TA; Lavan, BE; Lenhard, J; Mu, Y; Rentzeperis, D; Sears, DD; Zhang, F	1

Other Studies

1 other study(ies) available for halofenate and Weight Gain

Article	Year
MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema. Molecular endocrinology (Baltimore, Md.), 2009, Volume: 23, Issue:7 Topics: 3T3-L1 Cells; Adipocytes; Animals; Cells, Cultured; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Drug Partial Agonism; Edema; Halofenate; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Models, Biological; PPAR gamma; Rats; Rats, Zucker; Stereoisomerism; Substrate Specificity; Thiazolidinediones; Transcriptional Activation; Weight Gain	2009

Article

Year

MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema.

Molecular endocrinology (Baltimore, Md.), 2009, Volume: 23, Issue:7

Topics: 3T3-L1 Cells; Adipocytes; Animals; Cells, Cultured; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Drug Partial Agonism; Edema; Halofenate; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Models, Biological; PPAR gamma; Rats; Rats, Zucker; Stereoisomerism; Substrate Specificity; Thiazolidinediones; Transcriptional Activation; Weight Gain

2009